Trials / Unknown
UnknownNCT02108756
Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 272 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and Efficacy of L- Pantoprazole sodium to treat upper gastrointestinal ulcer bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-pantoprazole sodium | 2 injection L-pantoprazole sodium (40mg), Bid |
| DRUG | Panmeilu | An injection Panmeilu (80 mg) + 1 branch placebo, Bid; |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-04-01
- Completion
- 2015-06-01
- First posted
- 2014-04-09
- Last updated
- 2014-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02108756. Inclusion in this directory is not an endorsement.